HeartWare - About the company
HeartWare is an acquired company based in Framingham (United States), founded in 2005. It operates as a Global healthcare technology company specializing in medical devices and therapies. HeartWare has raised $12.4M in funding. The company has 99 active competitors, including 58 funded and 13 that have exited. Its top competitors include companies like CVRx, Impulse Dynamics and CorWave.
Company Details
Global healthcare technology company specializing in medical devices and therapies. It offers a wide array of products and services for healthcare professionals and patients, focusing on improving lives through innovative medical solutions. The company operates in various therapeutic areas, including cardiac rhythm management, diagnostics, cardiovascular, diabetes, neurological, spinal, and surgical solutions. It provides access to instruments, product resources, and reimbursement support. The company supports remote monitoring, patient services, and health monitoring. It focuses on engineer career, inclusion & diversity, and planet communities. The company offers digital ordering and services, education & training through Medtronic Academy, and MRI resources. It provides solutions for acute care, bariatric surgery, cardiac surgery, colon & rectal surgery, electrophysiology, gastroenterology, gynecology, hernia repair surgery, interventional cardiology, lung health, neurology, pain management, spine surgery, and surgical robotics.
Key Metrics
Founded Year
2005
Location
Framingham, United States
Stage
Acquired
Total Funding
$12.4M in 3 rounds
Latest Funding Round
Investors
Ranked
20th among 99 active competitors
Employee Count
103 as on May 31, 2026
Exit Details
Acquired by Medtronic (Jun 27, 2016)
Legal entities associated with HeartWare
HeartWare is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Heartware, Inc. CIN: 550828419 , United States, Active | Dec 31, 1999 | - | 547 (As on Dec 31, 2015) | - |
HeartWare's acquisition details
Click here to take a look at HeartWare's acquisition in detail
Sign up to download HeartWare's company profile
HeartWare's funding and investors
HeartWare has raised a total funding of $12.4M over 3 rounds. Its first funding round was on Aug 15, 2007. HeartWare has 2 institutional investors.
Here is the list of recent funding rounds of HeartWare:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Sep 25, 2009 | 5543703 | Post IPO | 8552558 | 3908208 | 6314298 | 3748964 |
Aug 10, 2009 | 7923384 | Post IPO | 3054332 | 3226649 | 1307918 | 9447325 |
Aug 15, 2007 | 4227841 | Series A | 8042853 | 2893040 | 1687903 | 6882999 |
Access funding benchmarks and valuations. Sign up today!View details of HeartWare's funding rounds and investors
HeartWare's founders and board of directors
Founder? Claim ProfileHeartWare's employee count trend
HeartWare has 103 employees as of May 26. Here is HeartWare's employee count trend over the years:
Uncover HeartWare's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
HeartWare's Competitors and alternates
Top competitors of HeartWare include CVRx, Impulse Dynamics and CorWave. Here is the list of Top 10 competitors of HeartWare, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | CVRx 2001, Minneapolis (United States), Public | Developer of implantable technology for hypertension and heart failure | $394M | 68/100 | |
2nd | Impulse Dynamics 1998, Marlton (United States), Series F | Provider of implantable device for treatment of chronic heart failure | $685M | 64/100 | |
3rd | Developer of implantable blood pumps for the treatment of heart failure | $127M | 61/100 | ||
4th |  Element Science 2013, San Francisco (United States), Series C | Wearable therapeutic device for treating sudden cardiac arrest | $193M | 61/100 | |
5th | SynCardia 2001, Tucson (United States), Public | Artificial heart | $72M | 60/100 | |
6th | Restore Medical 2016, Tel Aviv (Israel), Series B | Catheter-delivered implant for treatment of congestive heart failure | $32M | 58/100 | |
7th | InterShunt Technologies 2015, Louisiana (United States), Series B | Developer of cardiac catheter for the treatment of cardiac diseases | $26.6M | 57/100 | |
8th | Developer of an implantable cardiovascular device for treating heart failures | $51.9M | 57/100 | ||
9th | Corvia Medical 2009, Tewksbury (United States), Acquired | Developer of transcatheterally shunt for treating diastolic heart failure disease | $160M | 57/100 | |
10th | Reprieve Cardiovascular 2018, Milford (United States), Series B | Developer of decongestion management solution for acute decompensated heart failure patients | $150M | 56/100 | |
20th | HeartWare 2005, Framingham (United States), Acquired | Global healthcare technology company specializing in medical devices and therapies | $12.4M | 47/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on HeartWare's competitors? Click here to see the top ones
HeartWare's Investments and acquisitions
HeartWare has made 1 investment in Valtech and acquired World Heart Corporation.Reports related to HeartWare
Here is the latest report on HeartWare's geography:
News related to HeartWare
•
BioSig Technologies taps seasoned life sciences exec Brenda Castrodad to lead HR departmentProactive Investors•Feb 17, 2021•BioSig, HeartWare
•
CorWave Appoints Jim Schuermann as an Independent DirectorBusiness Wire•Feb 11, 2020•CorWave, HeartWare
•
•
Medtronic’s HeartWare Can’t Slip Investors Class Action Over Failed MVAD TrialMedical Buyer•Mar 20, 2018•HeartWare
•
Medtronic’s HeartWare launches new HVAD controller, recalls older modelsMassDevice•Mar 20, 2017•HeartWare
•
Edwards Lifesciences to acquire Valtech Cardio in $690m dealMassDevice•Nov 28, 2016•Edwards Lifesciences, Valtech, Valtech, HeartWare
•
HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd.PR Newswire•Sep 01, 2015•Valtech, HeartWare
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about HeartWare
Explore our recently published companies
- Wisdom Square Technologies - New Hyde Park based, 2008 founded, Unfunded company
- Fruverpack - Almoradi based, 1992 founded, Unfunded company
- AERA - Bouxwiller based, 1979 founded, Unfunded company
- Divine Hindu - Ujjain based, 2023 founded, Unfunded company
- Globaldigitalpartner.com - 2013 founded, Unfunded company
- OROK - Bourgoin Jallieu based, 2018 founded, Deadpooled company
